Incidence and risk factors of coronary heart disease in elderly patients on chronic hemodialysis

International Urology and Nephrology

Volumn 38, Issue 3-4, 2006, Pages 795-800

  Soubassi, Lygeri P ^a   Chiras, Theodore C ^a   Papadakis, Emmanuel D ^a   Poulos, George D ^a   Chaniotis, Dimitrios I ^a   Tsapakidis, Ioannis P ^a   Soubassi, Sofia P ^a   Zerefos, Stylianos N ^a   Zerefos, Nikolaos S ^a   Valis, Dimitrios A ^a  

^a HYGEIA HOSPITAL   (Greece)

Author keywords

Chronic hemodialysis; Coronary heart disease; Elderly; Incidence; Risk factors

Indexed keywords

C REACTIVE PROTEIN; DIPYRIDAMOLE; HOMOCYSTEINE; PARATHYROID HORMONE; THALLIUM CHLORIDE TL 201;

AGE; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ELDERLY CARE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPERVOLEMIA; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

AGED; CORONARY DISEASE; FEMALE; HUMANS; INCIDENCE; MALE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33847351677     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-006-0039-9     Document Type: Article

References (39)

1. Trespalacios FC, Taylor AJ, Agodoa LY and Abbott KC (2002). Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney Int 62(5): 1799-1805
2. Murphy SW, Foley RN and Parfrey PS (1998). Screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis 32: S184-S199
3. Massy ZA (2000). Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients. Nephrol Dial Transplant 15: 81-91
4. Vaziri ND (2004). Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93-99
5. Shlipak MG, Fried LF and Cushman M (2005). Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA 293: 1737-1745
6. Parfrey PS (2000). Cardiac disease in dialysis patients: Diagnosis, burden of disease, prognosis, risk factors and management. Nephrol Dial Transplant 15: 58-68
7. Meyer KB and Levey AS (1998). Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32: 853-906
8. Foley RN, Parfrey PS and Sarnak MJ (1998). Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32: S112-S119
9. Herzog CA, Ma JZ and Collins AJ (2002). Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106: 2207-2211
10. Rostand SG, Kirk KA and Rutsky EA (1984). Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25: 653-659
11. London GM and Parfrey PS (1997). Cardiac disease in chronic uremia: pathogenesis. Adv Ren Replace Ther 4: 194-211
12. Cheung AK, Sarnak MJ and Yan G (2000). Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58: 353-362
13. Longenecker JC, Coresh J and Powe NR (2002). Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 13: 1918-1927
14. Mallamaci F, Zoccali C and Tripepi G (2002). Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 61: 609-614
15. United States Renal Data System Excerpts from the USRDS 2004 annual data report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2005; 45(Suppl 1): S1.
16. Psaty BM, Furberg CD and Kuller LH (1999). Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The Cardiovascular Health Study. Arch Intern Med 159: 1339
17. Newman AB (2001). Coronary artery calcification in older adults to age 99: Prevalence and risk factors. Circulation 104(22): 2679-2684
18. Seyrek N, Balal M and Karayaylali I (2003). Which parameter is more influential on the development of arteriosclerosis in hemodialysis patients?. Ren Fail 25: 1011-1018
19. Dahan M, Viron BM and Faraggi M (1998). Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 54: 255-262
20. Volpato S, Guralnik J and Ferrucci L (2001). Cardiovascular disease, interleukin-6, and risk of mortality in older women: The women's health and aging study. Circulation 103: 947-953
21. Schimidt A, Stefenelli Th, Schnster E and Mayer G (2001). Informational contribution of noninvasive screening tests for coronary artery disease in patients on chronic renal replacement therapy. Am J Kidney Dis 37: 56-63
22. US Preventative Services Task Force. Guide to Clinical Preventative Services, 2nd ed. Baltimore, MD: Williams and Williams, 1996
23. Sugiura M, Hiraoka K and Ohkawa S (1976). Severity of coronary sclerosis in the aged: A pathological study in 968 consecutive autopsy cases. Jpn Heart J 17: 471
24. Rabbat CG, Treleaven DJ and Russell JD (2003). Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. J Am Soc Nephrol 14: 431-439
25. Beattie JN, Soman SS and Sandberg KR (2001). Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 37: 1191-1200
26. Hase H, Jokin N and Ishikawa H (2004). Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 19(5): 1161-1167
27. Best PJ, Lennon R and Ting HH (2002). The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39: 1113-1119
28. Kronenberg F, Neyer U and Lhotta K (1999). The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: A prospective follow-up. J Am Soc Nephrol 10: 1027-1036
29. Sarnak MJ, Levey AS and Schoolwerth AC (2003). Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169
30. Himmelfarb J, Stenvinkel P, Ikizler TA and Hakim RM (2002). The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 62: 1524-1438
31. Xia H, Ebben J, Ma JZ and Collins AJ (1999). Hematocrit levels and hospitalization risks in hemodialysis patients. J Am Soc Nephrol 10: 1309-1316
32. Boaz M, Smetana S and Weinstein T (2000). Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): Randomized placebo-controlled trial. Lancet 356: 1213-1218
33. Vaziri ND, Dicus M and Ho ND (2003). Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179-185
34. Santoro A and Mancini E (2002). Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant 17: 10-15
35. Kasiske BL, Ramos EL and Gaston RS (1995). The evaluation of renal transplant candidates: Clinical practice guidelines. J Am Soc Nephrol 6: 3431-3439
36. Longenecker JC, Klag MJ and Marcovina SM (2002). Small apolipoprotein (a) size predicts mortality in end-stage renal disease: The CHOICE study. Circulation 106: 2812-2818
37. Muntner P, He J and Hamm L (2002). Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745
38. Longenecker JC, Coresh J and Powe NR (2002). Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE study. J Am Soc Nephrol 13: 1918
39. Landray MJ, Thambyrajah J and McGlynn FJ (2001). Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38: 537